机构：[1]Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese andWestern Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China广东省中医院[2]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China广东省中医院[3]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China广东省中医院[4]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China深圳市中医院深圳医学信息中心[5]The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
This work was supported by the National Natural Science
Foundation of China (No. 82004373, 82074165,
81873306, 81973526, 82004132, 82174165); State Key Laboratory
of Dampness Syndrome of Chinese Medicine
(No. SZ2021ZZ19); Guangdong Science and TechnologyDepartment (No. 2016A030306025); Science and Technology
Planning Project of Guangdong Province (No.
2021A0505030059, 2017B030314166); Department of Education
of Guangdong Province (No. 2018KZDXM022,
A1-2606-19-111-009, 2019KQNCX019); The 2020 Guangdong
Provincial Science and Technology Innovation
Strategy Special Fund (Guangdong-Hong Kong-Macau
Joint Lab), (No. 2020B1212030006); Traditional Chinese
Medicine Bureau of Guangdong Province (No.
20201132, 20211114, 20212085, 20225011); Guangdong Medical
Research Foundation (No. 20201119103046743);
Guangzhou Science and Technology Project (No.
202102010316, 202102010241, 201904010407); The Specific
Research Fund for TCM Science and Technology of
Guangdong provincial Hospital of Chinese Medicine (No.
YN2018MJ07, YN2018QJ08); the Foundation for Young
Scholars of Guangzhou University of Chinese Medicine
(No. QNYC20190101); Research Fund for Bajian Talents of
Guangdong Provincial Hospital of Chinese Medicine (No.
BJ2022KY18, BJ2022KY12).
第一作者机构：[1]Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese andWestern Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[2]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China[4]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
共同第一作者：
通讯作者：
通讯机构：[1]Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese andWestern Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[2]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China[3]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China[4]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[5]The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[*1]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 55, Inner Road West, Higher Education Mega Center, Guangzhou 510006, China.
推荐引用方式(GB/T 7714)：
Zheng Yifeng,Wang Neng,Wang Shengqi,et al.Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells[J].CLINICAL AND TRANSLATIONAL MEDICINE.2023,13(2):doi:10.1002/ctm2.1119.
APA：
Zheng Yifeng,Wang Neng,Wang Shengqi,Pan Bo,Yang Bowen...&Wang Zhiyu.(2023).Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells.CLINICAL AND TRANSLATIONAL MEDICINE,13,(2)
MLA：
Zheng Yifeng,et al."Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells".CLINICAL AND TRANSLATIONAL MEDICINE 13..2(2023)
医学